1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by OTC Anti-Infective Products Revenue
1.4 Market Analysis by Type
1.4.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antifungals
1.4.3 Antiseptic
1.4.4 Antiparasitics
1.5 Market by Application
1.5.1 Global OTC Anti-Infective Products Market Share by Application: 2021-2026
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global OTC Anti-Infective Products Market
1.8.1 Global OTC Anti-Infective Products Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global OTC Anti-Infective Products Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2015-2020)
2.3 Global OTC Anti-Infective Products Average Price by Manufacturers (2015-2020)
2.4 Manufacturers OTC Anti-Infective Products Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global OTC Anti-Infective Products Sales Volume Market Share by Region (2015-2020)
3.2 Global OTC Anti-Infective Products Sales Revenue Market Share by Region (2015-2020)
3.3 North America OTC Anti-Infective Products Sales Volume
3.3.1 North America OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.3.2 North America OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia OTC Anti-Infective Products Sales Volume
3.4.1 East Asia OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe OTC Anti-Infective Products Sales Volume (2015-2020)
3.5.1 Europe OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.5.2 Europe OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia OTC Anti-Infective Products Sales Volume (2015-2020)
3.6.1 South Asia OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia OTC Anti-Infective Products Sales Volume (2015-2020)
3.7.1 Southeast Asia OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East OTC Anti-Infective Products Sales Volume (2015-2020)
3.8.1 Middle East OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa OTC Anti-Infective Products Sales Volume (2015-2020)
3.9.1 Africa OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.9.2 Africa OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania OTC Anti-Infective Products Sales Volume (2015-2020)
3.10.1 Oceania OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America OTC Anti-Infective Products Sales Volume (2015-2020)
3.11.1 South America OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.11.2 South America OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World OTC Anti-Infective Products Sales Volume (2015-2020)
3.12.1 Rest of the World OTC Anti-Infective Products Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World OTC Anti-Infective Products Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America OTC Anti-Infective Products Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia OTC Anti-Infective Products Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe OTC Anti-Infective Products Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia OTC Anti-Infective Products Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia OTC Anti-Infective Products Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East OTC Anti-Infective Products Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa OTC Anti-Infective Products Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania OTC Anti-Infective Products Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America OTC Anti-Infective Products Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World OTC Anti-Infective Products Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global OTC Anti-Infective Products Sales Volume Market Share by Type (2015-2020)
14.2 Global OTC Anti-Infective Products Sales Revenue Market Share by Type (2015-2020)
14.3 Global OTC Anti-Infective Products Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global OTC Anti-Infective Products Consumption Volume by Application (2015-2020)
15.2 Global OTC Anti-Infective Products Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in OTC Anti-Infective Products Business
16.1 GlaxoSmithKline
16.1.1 GlaxoSmithKline Company Profile
16.1.2 GlaxoSmithKline OTC Anti-Infective Products Product Specification
16.1.3 GlaxoSmithKline OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Roche
16.2.1 Roche Company Profile
16.2.2 Roche OTC Anti-Infective Products Product Specification
16.2.3 Roche OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Novartis
16.3.1 Novartis Company Profile
16.3.2 Novartis OTC Anti-Infective Products Product Specification
16.3.3 Novartis OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Merck
16.4.1 Merck Company Profile
16.4.2 Merck OTC Anti-Infective Products Product Specification
16.4.3 Merck OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Bristol-Myers Squibb
16.5.1 Bristol-Myers Squibb Company Profile
16.5.2 Bristol-Myers Squibb OTC Anti-Infective Products Product Specification
16.5.3 Bristol-Myers Squibb OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Pfizer
16.6.1 Pfizer Company Profile
16.6.2 Pfizer OTC Anti-Infective Products Product Specification
16.6.3 Pfizer OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Novabay Pharmaceuticals
16.7.1 Novabay Pharmaceuticals Company Profile
16.7.2 Novabay Pharmaceuticals OTC Anti-Infective Products Product Specification
16.7.3 Novabay Pharmaceuticals OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Sanofi
16.8.1 Sanofi Company Profile
16.8.2 Sanofi OTC Anti-Infective Products Product Specification
16.8.3 Sanofi OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Abbott
16.9.1 Abbott Company Profile
16.9.2 Abbott OTC Anti-Infective Products Product Specification
16.9.3 Abbott OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 NanoViricides
16.10.1 NanoViricides Company Profile
16.10.2 NanoViricides OTC Anti-Infective Products Product Specification
16.10.3 NanoViricides OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Optimer Pharmaceuticals
16.11.1 Optimer Pharmaceuticals Company Profile
16.11.2 Optimer Pharmaceuticals OTC Anti-Infective Products Product Specification
16.11.3 Optimer Pharmaceuticals OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Basilea Pharmaceutica
16.12.1 Basilea Pharmaceutica Company Profile
16.12.2 Basilea Pharmaceutica OTC Anti-Infective Products Product Specification
16.12.3 Basilea Pharmaceutica OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 MerLion Pharma
16.13.1 MerLion Pharma Company Profile
16.13.2 MerLion Pharma OTC Anti-Infective Products Product Specification
16.13.3 MerLion Pharma OTC Anti-Infective Products Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 OTC Anti-Infective Products Manufacturing Cost Analysis
17.1 OTC Anti-Infective Products Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of OTC Anti-Infective Products
17.4 OTC Anti-Infective Products Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 OTC Anti-Infective Products Distributors List
18.3 OTC Anti-Infective Products Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of OTC Anti-Infective Products (2021-2026)
20.2 Global Forecasted Revenue of OTC Anti-Infective Products (2021-2026)
20.3 Global Forecasted Price of OTC Anti-Infective Products (2015-2026)
20.4 Global Forecasted Production of OTC Anti-Infective Products by Region (2021-2026)
20.4.1 North America OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.2 East Asia OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.3 Europe OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.4 South Asia OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.6 Middle East OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.7 Africa OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.8 Oceania OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.9 South America OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World OTC Anti-Infective Products Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of OTC Anti-Infective Products by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of OTC Anti-Infective Products by Country
21.2 East Asia Market Forecasted Consumption of OTC Anti-Infective Products by Country
21.3 Europe Market Forecasted Consumption of OTC Anti-Infective Products by Countriy
21.4 South Asia Forecasted Consumption of OTC Anti-Infective Products by Country
21.5 Southeast Asia Forecasted Consumption of OTC Anti-Infective Products by Country
21.6 Middle East Forecasted Consumption of OTC Anti-Infective Products by Country
21.7 Africa Forecasted Consumption of OTC Anti-Infective Products by Country
21.8 Oceania Forecasted Consumption of OTC Anti-Infective Products by Country
21.9 South America Forecasted Consumption of OTC Anti-Infective Products by Country
21.10 Rest of the world Forecasted Consumption of OTC Anti-Infective Products by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer